Conference Description
The New Antibacterial Discovery and Development GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes a diverse range of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
The antibiotic resistance crisis is among us, and with it, the urgent need to tackle this global health threat has never been greater. Yet each step in the discovery and development process, from target validation and inhibitor optimization to clinical trial design and product commercialization, poses formidable challenges. The New Antibacterial Discovery and Development GCR will turn these challenges into opportunities to promote interdisciplinary innovation while addressing the global need for more effective antibiotic therapies.
The conference will offer a forum where participants of all backgrounds and career stages explore solutions to current bottlenecks in antibacterial drug development, creating bridges between Academia, Industry, and Governments. Importantly, the meeting will provide early career researchers and trainees ample networking opportunities with highly experienced leaders in a positive and inclusive environment. We hope to see you in Ventura!
The topics, speakers, and discussion leaders for the conference sessions are displayed below. The conference chair is currently developing their detailed program, which will include the complete meeting schedule, as well as the talk titles for all speakers. The detailed program will be available by November 18, 2023. Please check back for updates.
Keynote Session: Antibiotic Resistance and the Need for Novel Antibiotic Therapies
Discussion Leaders
-
Heike Broetz-Oesterhelt (University of Tübingen, Germany)
Speakers
-
David Weiss (Emory Antibiotic Resistance Center, United States)
-
George Zhanel (University of Manitoba, Canada)
-
Laura Piddock (Global Antibiotic R&D Partnership (GARDP), Switzerland)
-
Julian Hurdle (Texas A&M Health Science Center, United States)
-
Ursula Theuretzbacher (Center for Anti-Infective Agents, Austria)
Revitalizing Natural Product-Based Antibiotic Discovery
Discussion Leaders
-
Gerry Wright (McMaster University, Canada)
Speakers
-
Kim Lewis (Northeastern University, United States)
-
Jonathan Stokes (McMaster University, Canada)
-
Cesar de la Fuente (University of Pennsylvania, United States)
Antibacterial Targets: Are There Good Novel Targets?
Discussion Leaders
-
Kim Lewis (Northeastern University, United States)
Speakers
-
Deborah Hung (Harvard Medical School and Massachusetts General Hospital, United States)
-
Markus Weingarth (Utrecht University, The Netherlands)
The Bacterial Cell Envelope: Requirements for Drug Permeation
Discussion Leaders
-
Paul Hergenrother (University of Illinois at Urbana-Champaign, United States)
Speakers
-
Andrew Edwards (Imperial College London, United Kingdom)
-
Steven Rutherford (Genentech, United States)
From Hits to Leads to Candidates
Discussion Leaders
-
Ryan Cirz (Revagenix, Inc., United States)
Speakers
-
Yossef Av-Gay (University of British Columbia, Canada)
-
Holly Sutterlin (Prokaryotics Inc., United States)
-
Andrew Tomaras (Blacksmith Medicines, United States)
Advances in Antibiotic Combination Therapy
Discussion Leaders
-
Robert Bonomo (Cleveland VA Case Western Reserve University, United States)
Speakers
-
Olga Lomovskaya (Qpex Biopharma, United States)
-
Lori Burrows (McMaster University, Canada)
Unconventional Antibiotics. Phage Therapy, Antivirulence and Probiotics
Discussion Leaders
-
Eric Brown (McMaster University, Canada)
Speakers
-
Alexander Hynes (McMaster University, Canada)
-
Emma Allen-Vercoe (University of Guelph, Canada)
Moving the Needle for Difficult-to-Eradicate Infections
Discussion Leaders
-
Richard Lee (St. Jude Children's Research Hospital, United States)
Speakers
-
Vasan Sambandamurthy (Bugworks Research India Private Limited, India)
-
Thomas Dick (Hackensack Meridian Health, United States)
Learning from Failures and Moving to Success in Clinical Trials
Discussion Leaders
-
Vasan Sambandamurthy (Bugworks Research India Private Limited, India)
Speakers
-
Sven Hobbie (University of Zurich, Switzerland)
-
Subasree Srinivasan (GARDP, United States)
The GRC Power Hourâ„¢
Organizers
-
Dr. Gaynor Watson-Creed (Dalhousie University Faculty of Medicine, Canada)